Search research articles
Contact Us
Filters
Showing results (11-20 of 30) with videos related to
Page
of 3
Sort By:
Current Oncology (Toronto, Ont.)
|
July 21, 2021
Does the Time of Day at Which Endocrine Therapy Is Taken Affect Breast Cancer Patient Outcomes?
Ana-Alicia Beltran-Bless, Lisa Vandermeer, Mohammed F K Ibrahim, et al.
Journal of Bone Oncology
|
December 24, 2016
Strategies for obtaining bone biopsy specimens from breast cancer patients - Past experience and future directions
Mohammed F K Ibrahim, John Hilton, Christina Addison, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
May 3, 2015
Optimisation of steroid prophylaxis schedules in breast cancer patients receiving docetaxel chemotherapy-a survey of health care providers and patients
Carmel Jacobs, Brian Hutton, Sasha Mazzarello, et al.
Journal of Evaluation in Clinical Practice
|
June 11, 2015
Treatment choices for patients with invasive lobular breast cancer: a doctor survey
Carmel Jacobs, Mohamed F K Ibrahim, Mark Clemons, et al.
Critical Reviews in Oncology/Hematology
|
November 22, 2021
The current landscape of systemic therapy for recurrent glioblastoma: A systematic review of randomized-controlled trials
Francesco G T Fazzari, Foster Rose, Mehrnoosh Pauls, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica
|
December 22, 2021
Diagnostic assessment program for prostate cancer: Lessons learned after 2 years and degree of compliance to Canadian guidelines
Waleed Shabana, Ahmed Kotb, Daniel Tesolin, et al.
Breast Cancer Research and Treatment
|
October 27, 2016
Optimal primary febrile neutropenia prophylaxis for patients receiving docetaxel-cyclophosphamide chemotherapy for breast cancer: a systematic review
Ricardo Fernandes, Sasha Mazzarello, Carol Stober, et al.
Journal of Global Oncology
|
September 23, 2018
Primary Febrile Neutropenia Prophylaxis for Patients Who Receive FEC-D Chemotherapy for Breast Cancer: A Systematic Review
Ricardo Fernandes, Sasha Mazzarello, Carol Stober, et al.
Current Oncology (Toronto, Ont.)
|
March 27, 2024
Does Pre-Emptive Availability of PREDICT 2.1 Results Change Ordering Practices for Oncotype DX? A Multi-Center Prospective Cohort Study
Arif Ali Awan, Deanna Saunders, Gregory Pond, et al.
Clinical Breast Cancer
|
August 25, 2016
Optimal Management of Leptomeningeal Carcinomatosis in Breast Cancer Patients-A Systematic Review
Shaan Dudani, Sasha Mazzarello, John Hilton, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 30) with videos related to
Sort By:
Page
of 3
Current Oncology (Toronto, Ont.)
|
July 21, 2021
Does the Time of Day at Which Endocrine Therapy Is Taken Affect Breast Cancer Patient Outcomes?
Ana-Alicia Beltran-Bless, Lisa Vandermeer, Mohammed F K Ibrahim, et al.
Journal of Bone Oncology
|
December 24, 2016
Strategies for obtaining bone biopsy specimens from breast cancer patients - Past experience and future directions
Mohammed F K Ibrahim, John Hilton, Christina Addison, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
May 3, 2015
Optimisation of steroid prophylaxis schedules in breast cancer patients receiving docetaxel chemotherapy-a survey of health care providers and patients
Carmel Jacobs, Brian Hutton, Sasha Mazzarello, et al.
Journal of Evaluation in Clinical Practice
|
June 11, 2015
Treatment choices for patients with invasive lobular breast cancer: a doctor survey
Carmel Jacobs, Mohamed F K Ibrahim, Mark Clemons, et al.
Critical Reviews in Oncology/Hematology
|
November 22, 2021
The current landscape of systemic therapy for recurrent glioblastoma: A systematic review of randomized-controlled trials
Francesco G T Fazzari, Foster Rose, Mehrnoosh Pauls, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica
|
December 22, 2021
Diagnostic assessment program for prostate cancer: Lessons learned after 2 years and degree of compliance to Canadian guidelines
Waleed Shabana, Ahmed Kotb, Daniel Tesolin, et al.
Breast Cancer Research and Treatment
|
October 27, 2016
Optimal primary febrile neutropenia prophylaxis for patients receiving docetaxel-cyclophosphamide chemotherapy for breast cancer: a systematic review
Ricardo Fernandes, Sasha Mazzarello, Carol Stober, et al.
Journal of Global Oncology
|
September 23, 2018
Primary Febrile Neutropenia Prophylaxis for Patients Who Receive FEC-D Chemotherapy for Breast Cancer: A Systematic Review
Ricardo Fernandes, Sasha Mazzarello, Carol Stober, et al.
Current Oncology (Toronto, Ont.)
|
March 27, 2024
Does Pre-Emptive Availability of PREDICT 2.1 Results Change Ordering Practices for Oncotype DX? A Multi-Center Prospective Cohort Study
Arif Ali Awan, Deanna Saunders, Gregory Pond, et al.
Clinical Breast Cancer
|
August 25, 2016
Optimal Management of Leptomeningeal Carcinomatosis in Breast Cancer Patients-A Systematic Review
Shaan Dudani, Sasha Mazzarello, John Hilton, et al.
Page
of 3